Tuesday, January 31st 2012
I write this to clarify the circumstances in which we observed inhibition of the RIDL gene in mosquitoes fed on commercial cat food. Please share this with whoever may be concerned. In our laboratory at the Institut Pasteur, Paris, we study mosquitoes and mosquito-borne diseases. We are particularly interested in novel approaches to protect Human more »
Monday, January 16th 2012
OXFORD, UK, 16th January 2012 – Oxitec Ltd, a company pioneering a new approach to combating the mosquitoes that spread dengue fever, announced today that it has appointed Dr Christopher Richards as Non-Executive Chairman, with effect from 1st January 2012. Oxitec use advanced genetics to create ‘sterile’ male insects of the target species. The company more »
Friday, January 13th 2012
(CNS): Fears that genetically modified mosquitoes had bred and produced surviving offspring in the local population of insects are unfounded the director of Cayman’s Mosquito Research & Control Unit has said. Bill Petrie said that after the research study in Cayman undertaken by Oxitec the mosquitoes did not persist in the environment and there was more »
Friday, January 13th 2012
Oxitec and Certis Europe have entered into a research collaboration to develop, test and review commercial opportunities for Oxitec’s RIDL® technology on Tuta absoluta, one of the most economically damaging tomato crop pests in Europe. Oxitec’s patented RIDL® technology, similar in action to the sterile insect technique (SIT), allows for chemical-free, species-specific control of insect more »
Thursday, January 12th 2012
Oxitec statement in response to NGO allegations A press release by Friends of the Earth, GeneWatch and Third World Network is being circulated today, and makes inaccurate public assertions about Oxitec’s motives, process and technology with the purpose of causing anxiety about the regulatory process. Oxitec was founded with the purpose of finding better ways more »
